Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

MLA

Mika Shapiro, et al. “Lymphocyte Activation Gene 3: A Novel Therapeutic Target in Chronic Lymphocytic Leukemia.” Haematologica, vol. 102, no. 5, May 2017. EBSCOhost, https://doi.org/10.3324/haematol.2016.148965.

APA

Mika Shapiro, Yair Herishanu, Ben-Zion Katz, Nili Dezorella, Clare Sun, Sigi Kay, Aaron Polliack, Irit Avivi, Adrian Wiestner, & Chava Perry. (2017). Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia. Haematologica, 102(5). https://doi.org/10.3324/haematol.2016.148965

Chicago

Mika Shapiro, Yair Herishanu, Ben-Zion Katz, Nili Dezorella, Clare Sun, Sigi Kay, Aaron Polliack, Irit Avivi, Adrian Wiestner, and Chava Perry. 2017. “Lymphocyte Activation Gene 3: A Novel Therapeutic Target in Chronic Lymphocytic Leukemia.” Haematologica 102 (5). doi:10.3324/haematol.2016.148965.